Atlas Trials

Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study

Clinical trial NCT00131274 · COMPLETED

Trial details

NCT number
NCT00131274
Sponsor
Daniels, Craig E., M.D.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Idiopathic Pulmonary FibrosisLung DiseasePulmonary Fibrosis
Start date
2003-04-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.